A SURVEY TO STUDY THE CORRELATION BETWEEN THE SERUM LEVELS OF BONE TURNOVER MARKERS AND THE CLINICAL PICTURE IN PATIENTS WITH BREAST CANCER AND BONE METASTASES RECEIVING IBRADONIC ACID TREATMENT
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Breast cancer; Male breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Roche
- 22 Sep 2015 New trial record